• IGFBP3 inhibits lung cancer cell spheroid growth (3D proliferation). • IGFBP3 inhibits invasion by reduction of MMP activity. • Higher IGFBP3 plasma levels correlates with a less aggressive tumor. • Increased plasma levels is associated with improved overall cancer patient survival.